European researchers are urged to do more trials in children, conference hearsBMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2350 (Published 28 March 2012) Cite this as: BMJ 2012;344:e2350
- Elizabeth Sukkar
European paediatricians and drug company researchers were urged to conduct more clinical trials in children after slow progress in responding to European Union paediatric regulations that gave incentives to boost clinical research (BMJ 2007;335:1221). Currently many drugs licensed for adults have not been tested in children and are used off label.
“We want more trials done, but also more in Europe. We have been disappointed in the small increase in the number of clinical trials in Europe,” Agnès Saint Raymond, head of human medicines special areas at the European Medicines Agency (EMA), told the annual meeting of the European network of paediatric research at the EMA (Enpr-EMA) in Canary Wharf.
She estimates that the proportion of clinical trials in children has risen from 7-9% of studies in 2007 to around 12% now. The EU …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial